Tensile Capital Management Llc decreased Cornerstone Ondemand Inc (CSOD) stake by 9.61% reported in 2017Q3 SEC filing. Tensile Capital Management Llc sold 162,254 shares as Cornerstone Ondemand Inc (CSOD)’s stock declined 14.40%. The Tensile Capital Management Llc holds 1.53 million shares with $62.01M value, down from 1.69 million last quarter. Cornerstone Ondemand Inc now has $2.26B valuation. The stock increased 0.26% or $0.1 during the last trading session, reaching $39.1. About 864,527 shares traded or 63.53% up from the average. Cornerstone OnDemand, Inc. (NASDAQ:CSOD) has risen 0.77% since February 15, 2017 and is uptrending. It has underperformed by 15.93% the S&P500.
Analysts expect ProQR Therapeutics N.V. (NASDAQ:PRQR) to report $-0.49 EPS on February, 27.They anticipate $0.08 EPS change or 19.51% from last quarter’s $-0.41 EPS. After having $-0.49 EPS previously, ProQR Therapeutics N.V.’s analysts see 0.00% EPS growth. The stock increased 2.40% or $0.08 during the last trading session, reaching $3.2. About 51,631 shares traded. ProQR Therapeutics N.V. (NASDAQ:PRQR) has risen 37.60% since February 15, 2017 and is uptrending. It has outperformed by 20.90% the S&P500.
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA therapeutics for the treatment of genetic disorders. The company has market cap of $101.95 million. The Company’s lead product candidate includes QR-010, a RNA oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide that is designed to treat Leber's congenital amaurosis; and QR-313, a single-stranded oligonucleotide used for the treatment of epidermolysis bullosa. It currently has negative earnings. The firm has a research collaboration agreement with Galapagos N.V. to discover Axiomer Editing Oligonucleotides against fibrosis targets.
Among 5 analysts covering ProQR Therapeutics N.V. (NASDAQ:PRQR), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. ProQR Therapeutics N.V. had 6 analyst reports since March 15, 2016 according to SRatingsIntel. As per Monday, June 20, the company rating was initiated by Chardan Capital Markets. JMP Securities maintained ProQR Therapeutics N.V. (NASDAQ:PRQR) on Tuesday, March 15 with “Market Outperform” rating. The firm earned “Outperform” rating on Tuesday, September 26 by Leerink Swann. The rating was initiated by Janney Capital with “Neutral” on Thursday, September 29. The firm has “Buy” rating given on Tuesday, June 20 by H.C. Wainwright.
Since August 21, 2017, it had 0 insider buys, and 7 sales for $2.79 million activity. Another trade for 24,000 shares valued at $990,822 was made by Miller Adam L on Monday, September 18. On Thursday, September 14 BURLINGAME HAROLD W sold $80,000 worth of Cornerstone OnDemand, Inc. (NASDAQ:CSOD) or 2,000 shares. 2,000 shares valued at $79,760 were sold by Baker R C Mark on Friday, October 20.
Among 19 analysts covering Cornerstone OnDemand (NASDAQ:CSOD), 10 have Buy rating, 1 Sell and 8 Hold. Therefore 53% are positive. Cornerstone OnDemand had 50 analyst reports since August 5, 2015 according to SRatingsIntel. FBR Capital maintained it with “Buy” rating and $46.0 target in Wednesday, December 6 report. Wunderlich maintained the stock with “Buy” rating in Friday, November 4 report. The stock of Cornerstone OnDemand, Inc. (NASDAQ:CSOD) has “Buy” rating given on Thursday, November 9 by FBR Capital. As per Friday, August 5, the company rating was maintained by Wunderlich. J.P. Morgan upgraded it to “Hold” rating and $37.0 target in Wednesday, November 8 report. The firm has “Equal-Weight” rating by Barclays Capital given on Friday, July 15. On Wednesday, February 14 the stock rating was maintained by JP Morgan with “Neutral”. As per Monday, January 22, the company rating was upgraded by Bank of America. As per Friday, November 4, the company rating was downgraded by Needham. The stock of Cornerstone OnDemand, Inc. (NASDAQ:CSOD) has “Outperform” rating given on Wednesday, January 13 by FBR Capital.